RPL32P4

Across TCGA pan-cancer cohorts, RPL32P4 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPL32P4’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPL32P4 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL32P4 is over-expressed in tumor, although a few such as KIRC and BLCA show the opposite, repressed pattern.

KIRC, BLCA, and KIRP are the cancer types where RPL32P4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL32P4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	IV	−0.146	<.001	10	view →
BLCA	Female	All	−0.173	.021	4	view →
KIRP	All	All	−0.118	.003	4	view →
LIHC	All	All	+0.059	.002	4	view →
KICH	Male	All	+0.336	.023	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RPL32P4–KIRC

Open the KIRC breakdown →